| Wichita Foot And Ankle Wound Center | |
|
220 S Hillside St Ste B, Wichita, KS 67211-2151 | |
| (316) 755-8004 | |
| (316) 652-9913 |
| Full Name | Wichita Foot And Ankle Wound Center |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 220 S Hillside St Ste B, Wichita, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750752960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (* (Not Available)) | Primary |
| Provider Name | Christopher Henry Surtman |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1194759787 PECOS PAC ID: 5890738371 Enrollment ID: I20060816000114 |
News Archive
New research released today shows teenagers respond differently to drugs than adults and explores the long-lasting effects of drug use on brain development. One study shows people who start using drugs at a young age have greater cognitive shortfalls, including mental flexibility. Animal studies also suggest adolescents are more susceptible to lower doses of cocaine, are willing to work more for a cocaine "fix" than adults, and are at risk of developing compromised stress responses.
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Medtronic, Inc., announced today that an appeals court in Germany has found that the CoreValve® transcatheter aortic valve system does not infringe Edwards Lifesciences' German Andersen patent, which is set to expire in May 2011. The appellate court's decision upholds a lower court's ruling and enables uninterrupted access to the leading transcatheter heart valve in Germany.
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, announces the initiation of two further programmes under its existing alliance with GSK covering novel RNA-based treatments for Duchenne Muscular Dystrophy (DMD). The initiation of these additional programs under the terms of the existing alliance agreement is a validation of both the potential of Prosensa's "exon skipping" platform and the ongoing relationship.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wichita Foot And Ankle Wound Center 2522 N Graystone Cir, Wichita, KS 67228-8039 Ph: (316) 755-8004 | Wichita Foot And Ankle Wound Center 220 S Hillside St Ste B, Wichita, KS 67211-2151 Ph: (316) 755-8004 |
News Archive
New research released today shows teenagers respond differently to drugs than adults and explores the long-lasting effects of drug use on brain development. One study shows people who start using drugs at a young age have greater cognitive shortfalls, including mental flexibility. Animal studies also suggest adolescents are more susceptible to lower doses of cocaine, are willing to work more for a cocaine "fix" than adults, and are at risk of developing compromised stress responses.
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Medtronic, Inc., announced today that an appeals court in Germany has found that the CoreValve® transcatheter aortic valve system does not infringe Edwards Lifesciences' German Andersen patent, which is set to expire in May 2011. The appellate court's decision upholds a lower court's ruling and enables uninterrupted access to the leading transcatheter heart valve in Germany.
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, announces the initiation of two further programmes under its existing alliance with GSK covering novel RNA-based treatments for Duchenne Muscular Dystrophy (DMD). The initiation of these additional programs under the terms of the existing alliance agreement is a validation of both the potential of Prosensa's "exon skipping" platform and the ongoing relationship.
› Verified 5 days ago
Midwestern Podiatry Services Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1740 N Fairview Ave, Suite 200, Wichita, KS 67203 Phone: 206-375-8681 | |
Podiatry Clinic, P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 400 N Woodlawn St Ste 211, Wichita, KS 67208 Phone: 316-685-3801 Fax: 316-685-6901 | |
Aiman Nguib Milad Bishara, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1122 N Topeka St, Wichita, KS 67214 Phone: 316-866-2000 | |
Leila Galbraith Mckenzie Dpm Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 758 S Hillside St, Wichita, KS 67211 Phone: 316-686-2106 Fax: 316-686-5974 | |
Dr. Benjamin Watson Weaver, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1819 N Greenwich Rd, Suite B, Wichita, KS 67206 Phone: 316-269-3338 Fax: 316-264-5516 | |
Dr. Jon Robert Morgan, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 12112 W Kellogg St, Suite 300, Wichita, KS 67235 Phone: 316-440-1100 Fax: 316-440-1089 | |
Central Kansas Podiatry Associates Podiatrist Medicare: Medicare Enrolled Practice Location: 1819 N Greenwich Rd, Suite B, Wichita, KS 67206 Phone: 316-269-3338 Fax: 316-264-5516 |